Monitor the Lyme disease vaccine regulatory decision timeline over the next 12 months as the primary catalyst. The conference presentations may provide incremental pipeline updates but are unlikely to contain material new information.
Price Chart
Executive Summary
Valneva announced management participation in four upcoming healthcare conferences (Portzamparc/BNP Paribas, Guggenheim, Stifel, Jefferies) with fireside chats and investor meetings. The key discussion topic is the regulatory outlook for its partnered Lyme disease vaccine candidate, with decisions expected within 12 months. This is a routine investor relations activity with no new financial data or material business developments.
Key Facts
- Management will present at four conferences: Portzamparc BNP Paribas (Oct 15), Guggenheim (Nov 9), Stifel (Nov 10), Jefferies (Nov 16).
- Fireside chats will focus on the Lyme disease vaccine candidate (partnered with Pfizer) with regulatory decisions expected within 12 months.
- No financial results, guidance, or material agreements were disclosed in this filing.
Financial Impact
No financial figures disclosed; routine investor conference participation.
Risk Factors
- Lyme disease vaccine regulatory decision may be delayed or negative.
- No new financial data to assess current business performance.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-065954 |
| Document: a6-kcoverpagetemplate.htm | 0001628280-26-065954 |
| Document: 0001628280-26-065954-index-headers.html | 0001628280-26-065954 |
| Document: 0001628280-26-065954-index.html | 0001628280-26-065954 |
| Document: 0001628280-26-065954.txt | 0001628280-26-065954 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 13d ago | 6-K | $5.91 | awaiting T+20 | awaiting T+20 | $5.74 (−2.88%) |
Oct 8, 2026 20d ago | 6-K | $5.69 | awaiting T+20 | awaiting T+20 | $5.74 (+0.88%) |
Jun 17, 2026 19w ago | EFFECT | $5.35 $5.08 | ▼ −5.05% | ▼ −6.36% | $5.74 (+7.29%) |
Jun 5, 2026 20w ago | 6-K | $5.48 $5.40 | ▼ −1.46% | ▼ −3.32% | $5.74 (+4.74%) |
Jun 1, 2026 21w ago | 6-K | $5.95 $5.23 | ▼ −12.10% | ▼ −10.80% | $5.74 (−3.53%) |
May 5, 2026 25w ago | 6-K | $5.29 $5.63 | ▲ +6.43% | ▲ +1.47% | $5.74 (+8.51%) |
Mar 26, 2026 30w ago | 6-K | $6.32 $5.50 | ▼ −12.97% | ▼ −23.64% | $5.74 (−9.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers